BF-B Stock Analysis: Brown-Forman | NYSE
Beverages - Wineries & Distilleries | NYSE, USA | Market Cap: 12.109m USD | 12M Return: 5.7% | US1156372096 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 65.3M
EPS Trend: -61.3%
Qual. Beats: 0
Rev. Trend: -94.7%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Brown-Forman Corporation is a major global producer of alcoholic beverages, operating across the full value chain from manufacturing and distillation to bottling, importation, and marketing. The company participates in the Distillers & Vintners sub-industry within Consumer Staples, a sector characterized by brand-driven pricing power and regulatory exposure to alcohol distribution laws.
Its product portfolio spans spirits, wines, ready-to-drink cocktails, and ready-to-pour offerings, including whiskey, vodka, tequila, gin, brandy, rum, bourbon, and flavored liqueurs. Brown-Formans brand family is anchored by Jack Daniels and includes premium and super-premium labels such as Woodford Reserve, Old Forester, Gentleman Jack, Herradura, el Jimador, Fords Gin, The Glendronach, Chambord, Diplomático, Benriach, Glenglassaugh, and Slane. The company also sells used barrels, bulk whiskey and wine, and provides contract bottling services, adding ancillary revenue streams beyond branded packaged goods.
Distribution follows the three-tier system in the U.S., with products reaching consumers through distributors, state governments, retailers, wholesalers, and provincial governments. Internationally, Brown-Forman sells across key markets including Germany, Australia, the United Kingdom, Canada, Spain, France, Mexico, Poland, Brazil, and Türkiye.
Founded in 1870 and headquartered in Louisville, Kentucky, Brown-Forman trades on the NYSE under the ticker BF-B and is classified as a large-cap stock within Consumer Staples.
- Jack Daniels reported sales decline amid distributor destocking cycle
- Premium tequila portfolio gains offset whiskey category softness
- European tariff exposure pressures international operating margins
| Net Income: 721.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 4.67 > 1.0 |
| NWC/Revenue: 70.11% < 20% (prev 67.91%; Δ 2.21% < -1%) |
| CFO/TA 0.13 > 3% & CFO 1.01b > Net Income 721.0m |
| Net Debt (2.14b) to EBITDA (1.09b): 1.97 < 3 |
| Current Ratio: 3.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (459.3m) vs 12m ago -2.89% < -2% |
| Gross Margin: 60.66% > 18% (prev 59.02%; Δ 1.65% > 0.5%) |
| Asset Turnover: 48.95% > 50% (prev 48.32%; Δ 0.63% > 0%) |
| Interest Coverage Ratio: 9.94 > 6 (EBIT TTM 994.0m / Interest Expense TTM 100.0m) |
| A: 0.35 (Total Current Assets 3.96b - Total Current Liabilities 1.21b) / Total Assets 7.83b |
| B: 0.63 (Retained Earnings 4.96b / Total Assets 7.83b) |
| C: 0.12 (EBIT TTM 994.0m / Avg Total Assets 8.00b) |
| D: 1.03 (Book Value of Equity 3.97b / Total Liabilities 3.86b) |
| Altman-Z'' = 6.28 = AAA |
| DSRI: 0.98 (Receivables 822.0m/847.0m, Revenue 3.92b/3.95b) |
| GMI: 0.97 (GM 59.02% / 60.66%) |
| AQI: 1.00 (AQ_t 0.35 / AQ_t-1 0.35) |
| SGI: 0.99 (Revenue 3.92b / 3.95b) |
| TATA: -0.04 (NI 721.0m - CFO 1.01b) / TA 7.83b) |
| Beneish M = -3.08 (Cap -4..+1) = AA |
As of October 17, 2026, the stock is trading at USD 28.88 with a total of 3,479,229 shares traded. Over the past week, the price has changed by +9.44%, over one month by +12.20%, over three months by +12.19% and over the past year by +5.67%.
Current recommended Stop Loss: 28.00 (which is 3% or 1.3 ATR below the current price).
Brown-Forman has received a consensus analysts rating of 2.83. Therefore, it is recommended to hold BF-B.
- StrongBuy: 1
- Buy: 1
- Hold: 12
- Sell: 2
- StrongSell: 2
| Analysts Target Price | 28.3 | -2.1% |
P/E Trailing = 17.1364
P/E Forward = 15.5521
P/S = 3.0931
P/B = 3.0394
P/EG = 2.0047
Revenue TTM = 3.92b USD
EBIT TTM = 994.0m USD
EBITDA TTM = 1.09b USD
Long Term Debt = 2.08b USD (from longTermDebt, last quarter)
Short Term Debt = 358.0m USD (from shortTermDebt, last quarter)
Debt = 2.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.14b USD (calculated: Debt 2.44b - CCE 301.0m)
Enterprise Value = 14.2b USD (12.1b + Debt 2.44b - CCE 301.0m)
Interest Coverage Ratio = 9.94 (Ebit TTM 994.0m / Interest Expense TTM 100.0m)
EV/FCF = 15.40x (Enterprise Value 14.2b / FCF TTM 925.0m)
FCF Yield = 6.49% (FCF TTM 925.0m / Enterprise Value 14.2b)
FCF Margin = 23.63% (FCF TTM 925.0m / Revenue TTM 3.92b)
Net Margin = 18.42% (Net Income TTM 721.0m / Revenue TTM 3.92b)
Gross Margin = 60.66% ((Revenue TTM 3.92b - Cost of Revenue TTM 1.54b) / Revenue TTM)
Gross Margin QoQ = 60.26% (prev 62.61%)
Tobins Q-Ratio = 1.82 (Enterprise Value 14.2b / Total Assets 7.83b)
Interest Expense / Debt = 4.10% (Interest Expense 100.0m / Debt 2.44b)
Taxrate = 19.35% (173.0m / 894.0m)
NOPAT = 801.6m (EBIT 994.0m * (1 - 19.35%))
Current Ratio = 3.26 (Total Current Assets 3.96b / Total Current Liabilities 1.21b)
Debt / Equity = 0.62 (Debt 2.44b / totalStockholderEquity, last quarter 3.97b)
Debt / EBITDA = 1.97 (Net Debt 2.14b / EBITDA 1.09b)
Debt / FCF = 2.31 (Net Debt 2.14b / FCF TTM 925.0m)
Total Stockholder Equity = 4.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.01% (Net Income 721.0m / Total Assets 7.83b)
RoE = 17.80% (Net Income TTM 721.0m / Total Stockholder Equity 4.05b)
RoCE = 16.20% (EBIT 994.0m / Capital Employed (Equity 4.05b + L.T.Debt 2.08b))
RoIC = 11.83% (NOPAT 801.6m / Invested Capital 6.77b)
WACC = 5.45% (E(12.1b)/V(14.6b) * Re(5.88%) + D(2.44b)/V(14.6b) * Rd(4.10%) * (1-Tc(0.19)))
Discount Rate = 5.88% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -77.12 | Cagr: -1.61%
[DCF] Terminal Value 77.97% ; FCFF base≈788.6m ; Y1≈904.0m ; Y5≈1.33b
[DCF] Fair Price = 61.58 (EV 20.0b - Net Debt 2.14b = Equity 17.9b / Shares 290.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -61.27 | EPS CAGR: -8.13% | SUE: 0.10 | # QB: 0
Revenue Correlation: -94.73 | Revenue CAGR: -3.47% | SUE: -0.09 | # QB: 0
EPS current Quarter (2026-10-31): EPS=0.46 | Chg30d=+0.52% | Revisions=-15% | Analysts=14
EPS next Quarter (2027-01-31): EPS=0.51 | Chg30d=-1.23% | Revisions=-25% | Analysts=14
EPS current Year (2027-04-30): EPS=1.69 | Chg30d=+0.93% | Revisions=+7% | GrowthEPS=+10.7% | GrowthRev=+0.2%
EPS next Year (2028-04-30): EPS=1.71 | Chg30d=+0.78% | Revisions=+7% | GrowthEPS=+1.2% | GrowthRev=+1.8%
[Analyst] Revisions Ratio: -7% (up=19, down=22)